Impact of PD-L1 expression on the efficacy of first-line crizotinib in advanced ROS1-rearranged NSCLC. Xu Y, Zhang Y, Qiang H, Zhong H, et al. Lung Cancer 2024;194:107892.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu Y, Zhang Y, Qiang H, Zhong H, et al. Impact of PD-L1 expression on the efficacy of first-line crizotinib in advanced ROS1-rearranged NSCLC. Lung Cancer 2024;194:107892.
PMID: 39018704